Armstrong C. ACOG guidelines on noncontraceptive uses of hormonal contraceptives. Am Fam Physician. 2010 Aug;82:288-295. http://www.aafp.org/afp/2010/0801/p288.html. Accessed 03 Feb 2013
Black A, Francouer D, Rowe T, et al. SOGC clinical practice guidelines: Canadian contraception consensus. J Obstet Gynaecol Can. 2004 Mar;26(3):219-296. PMID: 15016334
Batur P, Elder J, Mayer M. Update on contraception: benefits and risks of the new formulations. Cleve Clin J Med. 2003 Aug;70(8):681-696. http://www.ncbi.nlm.nih.gov/pubmed/?term=12959393. PMID: 12959393
Dunn S, Guilbert E, Social Sexual Issues Committee. Emergency contraception. J Obstet Gynaecol Can. 2012 Sep;34(9):870-878. http://www.sogc.org. Accessed 03 Feb 2013. PMID: 22971457
Gupta N. Advances in hormonal contraception. Adolesc Med Clin. 2006 Oct;17(3):653-671. http://www.ncbi.nlm.nih.gov/pubmed/?term=17030284. PMID: 17030284
Guilbert E, Black A, Dunn S, et al. Missed hormonal contraceptives: new recommendations. J Obstet Gynaecol Can. 2008 Nov;30(11):1050-1062. http://www.ncbi.nlm.nih.gov/pubmed. PMID: 19126288
Dunn S, Guilbert E, Lefebvre G, et al. Emergency contraception. J Obstet Gynaecol Can. 2003 Aug;25(8):673-679. http://www.ncbi.nlm.nih.gov/pubmed/?term=12908020. PMID: 12908020
Milsom I, Korver T. Ovulation incidence with oral contraceptives: a literature review. J Fam Plann Reprod Health Care. 2008 Oct;34(4):237-246. http://www.ncbi.nlm.nih.gov/pubmed. PMID: 18854069
Platform for Action and the Beijing Declaration. Fourth World Conference on Women; Sep 4-5, 1995, Beijing, China. New York: United Nation's Department of Public Information. 1996 Sep;126(21):1-11. http://www.ncbi.nlm.nih.gov/pubmed. PMID: 12319677
Lesnewski R, Prine L. Initiating hormonal contraception. Am Fam Physician. 2006 Jul;74(1):105-112. PMID: 16848384
Korver Y, Klipping C, Hegar-Mahn D, et al. Maintenance of ovulation inhibition with 75-μg desogestrel-only contraceptive pill (Cerazette®) after scheduled 12-h delays in tablet intake. Contraception. 2005 Jan;71(1):8-13. http://www.ncbi.nlm.nih.gov/pubmed/?term=15639065. PMID: 15639065
Spencer AL, Bonnema R, McNamara MC. Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications. Am J Med. 2009 Jun;122(6):497-506. doi: 10.1016/j.amjmed.2009.01.016. PMID: 19486709
Robert AH, Anita LN. A Pocket Guide to Managing Contraception: Bridging the Gap Communications; 2003.
Mishell D, Stenchever M, Droegemueller W, et al. Oral steroid contraceptives. In: Stenchever M. Comprehensive Gynecology. 4th ed. St. Louis: Mosby; 2001:303-324.
Levine JP, Mravcak S, Wu J. Contraception. In: Rakel RE. Textbook of Family Medicine. 7th ed. Philadelphia: Saunders, Elsevier; 2007.
Darney PD. Hormonal contraception. In: Kronenberg HM, Melmed S, Polonsky KS, eds. Williams Textbook of Endocrinology. 11th ed. Philadelphia: Saunders, an imprint of Elsevier; 2008.
American College of Obstetricians and Gynecologists (ACOG). Emergency contraception. ACOG. http://www.acog.org/. Dec 2005.
Association of Reproductive Health Professionals (ARHP). A quick reference guide for clinicians. Choosing a birth control method. ARHP. http://www.arhp.org. Sep 2011. Accessed 03 Feb 2013.
Faculty of Sexual & Reproductive Healthcare (FSRH). Emergency contraception. FSRH. http://www.fsrh.org. Jan 2012. Accessed 03 Feb 2013.
World Health Organization (WHO). Improving access to quality care family planning. Medical eligibility criteria for contraceptive use, 2nd ed. WHO. http://www.who.int.
Faculty of Family Planning and Reproductive Healthcare Clinical Guidance. First prescription of combined oral contraception. Faculty of Sexual and Reproductive Healthcare. http://www.fsrh.org. Jan 2007.
The American College of Obstetricians and Gynecologists (ACOG). Natural family planning. Frequently asked questions. FAQ024. Contraception. ACOG. http://www.acog.org. Aug 2011. Accessed 04 Feb 2013.
Practical Support for Clinical Governance. Prodigy guidance-contraception. http://www.prodigy.nhs.uk. 2004.
Faculty of Family Planning and Reproductive Healthcare Clinical Guidance. Progesterone-only pills. Faculty of Sexual and Reproductive Healthcare. http://www.fsrh.org. Jun 2009.
Faculty of Family Planning and Reproductive Healthcare Effectiveness Unit. Progesterone-ony injectable contraception. Faculty of Sexual and Reproductive Healthcare. http://www.fsrh.org. Jun 2009.
Royal College of Obstetricians and Gynaecologists (RCOG). Venous thromboembolism and hormonal contraception. RCOG green-top guideline no. 40. RCOG. http://www.rcog.org.uk. Jul 2010. Accessed 03 Feb 2013.
Marshall J. Progestins in oral contraceptives: a comparative review. http://www.femalepatient.com. Feb 2003.
Caddy S, Yudin MH, Hakim J, et al; Infectious Disease Committee. Best practices to minimize risk of infection with intrauterine device insertion . J Obstet Gynaecol Can. 2014 Mar;36(3):266-276. http://sogc.org. PMID: 2461289
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep. 2013 Jun;62(RR-05):1-60. http://www.cdc.gov. PMID: 23784109
Department of Health. The Philippine clinical standards manual on family planning (2014 edition). Manila, Philippines: DOH; 2014. 29-134. Accessed 17 Aug 2015:29-134.
World Health Organization (WHO). Medical eligibility criteria for contraceptive use. 5th ed. Geneva, Switzerland: WHO; 2015. Accessed 18 Aug 2015.
Black A, Guilbert E, Costescu D, et al. Canadian contraception consensus (part 3 of 4): chapter 7 - intrauterine contraception. J Obstet Gynaecol Can. 2016 Feb;38(2):182-222. doi: 10.1016/j.jogc.2015.12.002. Accessed 17 Aug 2016. PMID: 27032746
Black A, Guilbert E, Costescu D, et al. Canadian contraception consensus (part 3 of 4): chapter 8 - progestin-only contraception. J Obstet Gynaecol Can. 2016 Mar;38(3):279-300. doi: 10.1016/j.jogc.2015.12.003. Accessed 17 Aug 2016. PMID: 27106200
Black A, Guilbert E, Costescu D, et al. No. 329-Canadian contraception consensus part 4 of 4 chapter 9: combined hormonal contraception. J Obstet Gynaecol Can. 2017 Apr;39(4):229-268.e5. doi: 10.1016/j.jogc.2016.10.005. Accessed 21 Apr 2017. PMID: 28413042
World Health Organization (WHO). Selected practice recommendations for contraceptive use, 3rd ed. WHO. http://apps.who.int. 2016. Accessed 21 Apr 2017.
Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group. ACOG practice bulletin no. 186: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2017 Nov;130(5):e251-e269. doi: 10.1097/AOG.0000000000002400. Accessed 09 Jul 2018. PMID: 29064972
Practice Committee of the American Society for Reproductive Medicine. Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertil Steril. 2017 Jan;107(1):43-51. doi: 10.1016/j.fertnstert.2016.09.027. Accessed 09 Jul 2018. PMID: 27793376
Sacco S, Merki-Feld GS, Ægidius KL, et al; EHF and ESC. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct 30;18(1):108. doi: 10.1186/s10194-017-0815-1. Accessed 09 Jul 2018. PMID: 29086160
World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge for Health Project. Family planning: a global handbook for providers (2018 update). World Health Organization. https://www.who.int/. 2018. Accessed 08 Nov 2018.
Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(4):1-66. doi: 10.15585/mmwr.rr6504a1. Accessed 08 Nov 2018. PMID: 27467319
Annovera highlights of prescribing information. U.S. Food & Drug Administration. https://www.accessdata.fda.gov. 2018. Accessed 09 Dec 2019.
Nelson AL. Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: a new year-long, patient controlled, reversible birth control method. Expert Rev Clin Pharmacol. 2019 Oct;12(10):953-963. doi: 10.1080/17512433.2019.1669448. Accessed 09 Dec 2019. PMID: 31526281
Black A, Guilbert E, Costescu D, et al. Canadian contraception consensus (part 1 of 4). J Obstet Gynaecol Can. 2015;37(10):936-942. doi: 10.1016/s1701-2163(16)30033-0. Accessed 17 Feb 2023. PMID: 26606712
Franik S, Bauersachs R, Beyer-Westendor J, et al. Hormonal contraception. Guideline of the DGGG, OEGGG and SGGG (S3 level, AWMF registry number 015/015, January 2020). Geburtshilfe Frauenheilkd. 2021 Feb;81(2):152-182. doi: 10.1055/a-1259-1609. Accessed 17 Feb 2023. PMID: 33623171
The Faculty of Sexual & Reproductive Healthcare (FSRH). FSRH guideline: combined hormonal contraception. FSRH. https://www.fsrh.org.uk/. Nov 2020.
